VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 536 filers reported holding VANECK VECTORS ETF TR in Q4 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,736,000 | +32.2% | 84,730 | +47.4% | 0.13% | +0.8% |
Q4 2020 | $2,070,000 | -7.6% | 57,471 | +0.5% | 0.12% | -16.1% |
Q3 2020 | $2,240,000 | +0.7% | 57,198 | -5.7% | 0.15% | -3.9% |
Q2 2020 | $2,224,000 | -73.9% | 60,634 | -83.6% | 0.16% | -81.1% |
Q1 2020 | $8,527,000 | -68.2% | 370,111 | -59.6% | 0.82% | -54.7% |
Q4 2019 | $26,849,000 | +11.6% | 916,970 | +1.8% | 1.81% | +7.8% |
Q3 2019 | $24,057,000 | -19.1% | 900,668 | -22.6% | 1.68% | -18.6% |
Q2 2019 | $29,754,000 | +11.0% | 1,164,068 | -2.6% | 2.06% | +9.8% |
Q1 2019 | $26,797,000 | +2598.6% | 1,195,215 | +2438.9% | 1.88% | +2435.1% |
Q4 2018 | $993,000 | +11.6% | 47,076 | -2.1% | 0.07% | +21.3% |
Q3 2018 | $890,000 | -4.7% | 48,074 | +14.8% | 0.06% | +8.9% |
Q2 2018 | $934,000 | -21.2% | 41,886 | -22.3% | 0.06% | -20.0% |
Q1 2018 | $1,185,000 | – | 53,935 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |